Advertisement
MCP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/mcp.M400221-MCP200 on July 26, 2005.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M400221-MCP200v1
4/11/1686    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Glossary
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, D.
Right arrow Articles by Koay, E. S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, D.
Right arrow Articles by Koay, E. S. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Molecular & Cellular Proteomics 4:1686-1696, 2005.
© 2005 by The American Society for Biochemistry and Molecular Biology, Inc.


Research

Proteomic Study Reveals That Proteins Involved in Metabolic and Detoxification Pathways Are Highly Expressed in HER-2/neu-positive Breast Cancer*

DaoHai Zhang{ddagger}, Lee Kian Tai§, Lee Lee Wong, Lily-Lily Chiu{ddagger}, Sunil K. Sethi{ddagger},§ and Evelyn S. C. Koay{ddagger},§,||

From the {ddagger} Department of Laboratory Medicine, National University Hospital, 5 Lower Kent Ridge Road, Singapore 119074, § Department of Pathology, National University of Singapore, 10 Kent Ridge Crescent, Singapore 119260, and Oncology Research Institute, National University of Singapore, Singapore 117597, Singapore

The receptor tyrosine kinase ErbB2 (HER-2/neu) is overexpressed in up to 30% of breast cancers and is associated with poor prognosis and an increased likelihood of metastasis especially in node-positive tumors. In this proteomic study, to identify the proteins that are associated with the aggressive phenotype of HER-2/neu-positive breast cancer, tumor cells from both HER-2/neu-positive and -negative tumors were procured by laser capture microdissection. Differentially expressed proteins in the two subsets of tumors were identified by two-dimensional electrophoresis and MALDI-TOF/TOF MS/MS. We found differential expression of several key cell cycle modulators, which were linked with increased proliferation of the HER-2/neu-overexpressing cells. Nine proteins involved in glycolysis (triose-phosphate isomerase (TPI), phosphoglycerate kinase 1 (PGK1), and enolase 1 (ENO1)), lipid synthesis (fatty acid synthase (FASN)), stress-mediated chaperonage (heat shock protein 27 (Hsp27)), and antioxidant and detoxification pathways (haptoglobin, aldo-keto reductase (AKR), glyoxalase I (GLO), and prolyl-4-hydrolase ß-isoform (P4HB)) were found to be up-regulated in HER-2/neu-positive breast tumors. HER-2/neu-dependent differential expression of PGK1, FASN, Hsp27, and GLO was further validated in four breast cancer cell lines and 12 breast tumors by immunoblotting and confirmed by partially switching off the HER-2/neu signaling in the high HER-2/neu-expressing SKBr3 cell line with Herceptin treatment. Statistical correlations of these protein expressions with HER-2/neu status were further verified by immunohistochemistry on a tissue microarray comprising 97 breast tumors. Our findings suggest that HER-2/neu signaling may result, directly or indirectly, in enhanced activation of various metabolic, stress-responsive, antioxidative, and detoxification processes within the breast tumor microenvironment. We hypothesize that these identified changes in the cellular proteome are likely to drive cell proliferation and tissue invasion and that the key cell cycle modulators involved, when uncovered by future research, would serve as naturally useful targets for the development of therapeutic strategies to negate the metastatic potential of HER-2/neu-positive breast tumors.


|| To whom correspondence should be addressed: Dept. of Pathology, Faculty of Medicine, National University of Singapore, 10 Kent Ridge Crescent, Singapore 119260, Singapore. Tel.: 65-67724564; Fax: 65-67780671; E-mail: patkoaye{at}nus.edu.sg


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BioinformaticsHome page
H. Pang, D. Datta, and H. Zhao
Pathway analysis using random forests with bivariate node-split for survival outcomes
Bioinformatics, January 15, 2010; 26(2): 250 - 258.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. V. Recktenwald, R. Kellner, R. Lichtenfels, and B. Seliger
Altered Detoxification Status and Increased Resistance to Oxidative Stress by K-Ras Transformation
Cancer Res., December 15, 2008; 68(24): 10086 - 10093.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
I. I. Daud and M. E. Scott
Validation of Reference Genes in Cervical Cell Samples from Human Papillomavirus-Infected and -Uninfected Women for Quantitative Reverse Transcription-PCR Assays
Clin. Vaccine Immunol., September 1, 2008; 15(9): 1369 - 1373.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
R. J. Gillies, I. Robey, and R. A. Gatenby
Causes and Consequences of Increased Glucose Metabolism of Cancers
J. Nucl. Med., June 1, 2008; 49(Suppl_2): 24S - 42S.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Ursini-Siegel, A. B. Rajput, H. Lu, V. Sanguin-Gendreau, D. Zuo, V. Papavasiliou, C. Lavoie, J. Turpin, K. Cianflone, D. G. Huntsman, et al.
Elevated Expression of DecR1 Impairs ErbB2/Neu-Induced Mammary Tumor Development
Mol. Cell. Biol., September 15, 2007; 27(18): 6361 - 6371.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
W. Lam, C.-H. Leung, S. Bussom, and Y.-C. Cheng
The Impact of Hypoxic Treatment on the Expression of Phosphoglycerate Kinase and the Cytotoxicity of Troxacitabine and Gemcitabine
Mol. Pharmacol., September 1, 2007; 72(3): 536 - 544.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Wang, J. Wang, J. Dai, Y. Jung, C.-L. Wei, Y. Wang, A. M. Havens, P. J. Hogg, E. T. Keller, K. J. Pienta, et al.
A Glycolytic Mechanism Regulating an Angiogenic Switch in Prostate Cancer
Cancer Res., January 1, 2007; 67(1): 149 - 159.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
N. S. Azad, N. Rasool, C. M. Annunziata, L. Minasian, G. Whiteley, and E. C. Kohn
Proteomics in Clinical Trials and Practice: Present Uses and Future Promise
Mol. Cell. Proteomics, October 1, 2006; 5(10): 1819 - 1829.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Lupu and J. A. Menendez
Targeting Fatty Acid Synthase in Breast and Endometrial Cancer: An Alternative to Selective Estrogen Receptor Modulators?
Endocrinology, September 1, 2006; 147(9): 4056 - 4066.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. P. Kuhajda
Fatty Acid synthase and cancer: new application of an old pathway.
Cancer Res., June 15, 2006; 66(12): 5977 - 5980.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. A. Menendez and R. Lupu
RESPONSE: Re: Effect of {gamma}-Linolenic Acid on the Transcriptional Activity of the Her-2/neu (erbB-2) Oncogene
J Natl Cancer Inst, May 17, 2006; 98(10): 718 - 720.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement